Human Embryonic Stem Cell-Derived Cardiomyocyte Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Human Embryonic Stem Cell-Derived Cardiomyocyte Therapy, covering 2025-09-29 to 2025-09-29. Get the full timeline:
Most recent: Clinical Trial Update: Human Embryonic Stem Cell-Derived Cardiomyocyte Therapy for Chronic Ischemic Left Ventricular Dysfunction [Phase 1]